University of Sydney
VC Fund
Sydney, Australia
University of Sydney is an Australian public research university that provides educational services.The university comprises 16 faculties and schools, through which it offers bachelor’s, master’s, and doctoral degrees. Its campuses include Camperdown and Darlington, Cumberland, AGSM, Mallett Street, Orange, Sydney Conservatorium of Music,Rozelle, Camden, Burren Street, and Surry Hills. Its faculties include arts, architecture, agriculture, food and natural resources, economics and business, education and social work, engineering, medicine, pharmacy, science, veterinary science, health sciences, management, law, English teaching, dentistry, transport studies, and international health.University Of Sydney was founded in 1850 and is headquartered in New South Wales, Australia.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries University of Sydney invests in
Stages University of Sydney invests in
Countries University of Sydney invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Biotechnology 2 (50%)
- Health Care 1 (25%)
- Therapeutics 1 (25%)
- Medical Device 1 (25%)
- Information Technology 1 (25%)
Stage
- Seed 1 (25%)
- Pre-Seed 1 (25%)
- Series A 1 (25%)
- Series B 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Archie Johnston
Dean
|
Dean | Total investments: 0 | Find email | |
Arne Geschke
Associate Professor
|
Associate Professor | Total investments: 0 | Find email | |
David Anstice
Adjunct Professor
|
Adjunct Professor | Total investments: 0 | Find email | |
Jean Jonathan Bogais
PhD, Adjunct Associate Professor
|
PhD, Adjunct Associate Professor | Total investments: 0 | Find email | |
Mark R Johnson
Lecturer in Digital Cultures
|
Lecturer in Digital Cultures | Total investments: 0 | Find email | |
| See all 13 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Oli
|
Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies. | $4.7M / Series A / May 26, 2026 | |
DeteQt
|
Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging | $3.5M / Seed / Apr 14, 2026 | |
Algenie
|
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is economically viable. | $731.9K / Pre-Seed / Sep 10, 2024 | |
Kinoxis Therapeutics
|
Kinoxis Therapeutics is an early stage biotechnology company based in Australia that is working to progress the development of a range of novel therapeutic compounds for the treatment of substance use disorders and other CNS conditions. The company has licensed these compounds from the University of Sydney, with the lead candidate demonstratingpotent anti-addictive and prosocial effects in a number of different animal models and is progressing through pre-clinical testing. | $9.5M / Series B / Aug 12, 2024 |
Co-Investors
Uniseed
2 deals together
ATP Fund
1 deal together
Avicella Capital
1 deal together
Beaten Zone Venture Partners
1 deal together
Better Bite Ventures
1 deal together
BOKA Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does University of Sydney invest in?
University of Sydney invests primarily in Biotechnology, Health Care and Therapeutics startups, most often at Seed and Pre-Seed stage. Most of the 4 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact University of Sydney?
Public channels for University of Sydney include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at University of Sydney?
The team at University of Sydney includes Archie Johnston (Dean), Arne Geschke (Associate Professor) and David Anstice (Adjunct Professor), among 13 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
